Supplementary Figure S3 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
Year: 2024
Type: supplementary-materials
Abstract: Figure S3: ARO-HIF2 Plasma Concentration-Time Profiles by Treatment and Dosing Week
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4399298248